Evaluation of effectiveness of Metformin and pioglitazone in women with polycystic ovary syndrome

Phase 2

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome

• Registration Number: IRCT201403101836N7
• Lead Sponsor: Shahid Sadoughi University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 75

Inclusion Criteria

age between 18 to 40 years old; diagnosed PCOS by AES (Androgen excess soiciety2006) criteria include:
1. Oligo or anovulation 2. Clinical or biochemical hyperandrogenism and rejection any other reasen cause to hyperandrogenism. Exclusion criteria: pregnancy and lactation; impaired liver and renal function tests; thyroid disorder; hyperprolactinemia; adrenal disorders; patient on estrogen and progesterone pills; the presence of type 1 and type 2 diabetes mellitus; late-onset congenital adrenal hyperplasia, and Cushing’s syndrome; none of the women had been taking clomiphene citrate, oral contraceptives, antiandrogens, insulin, minoxidil, phenytoin, cyclosporine, or drugs to control their appetite, lipid profile, during the previous 3 months and any severe systemic disease.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified